Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Shares Outstanding (Diluted Average): 2021-2023

Historic Shares Outstanding (Diluted Average) for Therapeutics (RAPT) over the last 3 years, with Dec 2023 value amounting to $38.3 million.

  • Therapeutics' Shares Outstanding (Diluted Average) rose 1.42% to $38.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $38.9 million, marking a year-over-year increase of 1.42%. This contributed to the annual value of $38.3 million for FY2023, which is 17.82% up from last year.
  • According to the latest figures from FY2023, Therapeutics' Shares Outstanding (Diluted Average) is $38.3 million, which was up 17.82% from $32.5 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $38.3 million in FY2023 and a low of $27.4 million during FY2021.
  • Over the past 3 years, Therapeutics' median Shares Outstanding (Diluted Average) value was $32.5 million (recorded in 2022), while the average stood at $32.8 million.
  • Data for Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY grew of 18.80% (in 2022) over the last 5 years.
  • Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $27.4 million in 2021, then grew by 18.80% to $32.5 million in 2022, then grew by 17.82% to $38.3 million in 2023.